Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03605810 · ClinicalTrials.gov registry record
Study to Develop a Tool to Estimate the Kidney Function in Databases Without Laboratory Data
A clinical trial, sponsored by Bayer.
- Completed
- Registry status
- 5,132,200
- Enrollment target
NCT03605810 is a clinical trial that has completed, run by Bayer. The registered enrollment target is 5,132,200 participants.
The verdict
NCT03605810 has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- 5,132,200 participants
- Enrollment target
Study Summary
Scientific analyses are frequently performed on e.g. health insurance databases to study the usage and effectiveness of drugs in real life. Kidney function is known to have an influence on a patients disease development and/or drug levels in blood. However, often direct measures for kidney function are not available in databases. This study plans to develop tools to classify the renal function of patients, which helps scientists to identify patient cohorts (groups of patients sharing same characteristics) for scientific analyses.
Interventions
- OTHER No Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,132,200 participants |
| Start Date | 2018-07-15 |
| Est. Completion | 2018-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03605810
The ClinicalTrials.gov registry entry for NCT03605810 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 5,132,200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bayer, which has 591 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No Intervention is the first listed.
NCT03605810 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03605810 about?
NCT03605810 is a clinical study titled "Study to Develop a Tool to Estimate the Kidney Function in Databases Without Laboratory Data". Scientific analyses are frequently performed on e.g. health insurance databases to study the usage and effectiveness of drugs in real life. Kidney function is known to have an influence on a patients disease development and/or drug levels in blood. However, often direct measures for kidney functio...
What is the current status of trial NCT03605810?
This trial is currently completed. The enrollment target is 5,132,200 participants. The study started on 2018-07-15. Estimated completion is 2018-12-31.
What interventions are being tested in trial NCT03605810?
The interventions under investigation include: No Intervention (OTHER).
Who is sponsoring clinical trial NCT03605810?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.